Literature DB >> 25715653

Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.

Leiping Fu1, Denise R Minton1, Tuo Zhang2, David M Nanus3, Lorraine J Gudas4.   

Abstract

UNLABELLED: Renal cell carcinoma (RCC) is the most common cancer arising from the kidney in adults, with clear cell RCC (ccRCC) representing the majority of all RCCs. Expression of a human HIF1α triple-mutant (P402A, P564A, and N803A) construct in the proximal tubule cells of C57BL/6 mice [TRAnsgenic model of Cancer of the Kidney (TRACK); ref. 1] mimics the histologic changes found in early stage human ccRCC. To better understand the genomic landscape, a high-throughput sequence analysis was performed with cDNA libraries (RNAseq) derived from TRACK transgenic positive (TG(+)) kidney cortex along with human ccRCC transcripts from the Oncomine and The Cancer Genome Atlas databases. Importantly, the expression profiles of TRACK TG(+) kidneys show significant similarities with those observed in human ccRCC, including increased expression of genes involved in glycolysis and the tricarboxylic acid cycle. Some of the transcripts overexpressed in both the TRACK mouse model and human ccRCC include ANKRD37, CA9, EGLN3, HK2, NDUFA4L2, and SLC16A3. These data suggest that constitutive activation of HIF1α in kidney proximal tubule cells transcriptionally reprograms the regulation of metabolic pathways in the kidney and that HIF1α is a major contributor to the altered metabolism observed in human ccRCC. IMPLICATIONS: TRACK (GGT-HIF1αM3) kidney mRNA profiles show similarities to human ccRCC transcriptome and phenotypes associated with the Warburg effect. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25715653      PMCID: PMC4433424          DOI: 10.1158/1541-7786.MCR-14-0423

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  37 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  HIF-1 and human disease: one highly involved factor.

Authors:  G L Semenza
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

3.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

4.  SIRT6: a master epigenetic gatekeeper of glucose metabolism.

Authors:  Lei Zhong; Raul Mostoslavsky
Journal:  Transcription       Date:  2010 Jul-Aug

5.  Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases.

Authors:  Bhuvaneswari Krishnan; Luan D Truong
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

6.  Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.

Authors:  Leiping Fu; Gang Wang; Maria M Shevchuk; David M Nanus; Lorraine J Gudas
Journal:  Cancer Res       Date:  2013-02-27       Impact factor: 12.701

7.  Abnormal cholesterol metabolism in renal clear cell carcinoma.

Authors:  R L Gebhard; R V Clayman; W F Prigge; R Figenshau; N A Staley; C Reesey; A Bear
Journal:  J Lipid Res       Date:  1987-10       Impact factor: 5.922

8.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

9.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  12 in total

1.  Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.

Authors:  Denise R Minton; Leiping Fu; Nigel P Mongan; Maria M Shevchuk; David M Nanus; Lorraine J Gudas
Journal:  Clin Cancer Res       Date:  2016-01-18       Impact factor: 12.531

Review 2.  The HIF and other quandaries in VHL disease.

Authors:  D Tarade; M Ohh
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

3.  Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma.

Authors:  Petra Miikkulainen; Heidi Högel; Fatemeh Seyednasrollah; Krista Rantanen; Laura L Elo; Panu M Jaakkola
Journal:  J Biol Chem       Date:  2019-01-07       Impact factor: 5.157

4.  The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.

Authors:  Amrita M Nargund; Can G Pham; Yiyu Dong; Patricia I Wang; Hatice U Osmangeyoglu; Yuchen Xie; Omer Aras; Song Han; Toshinao Oyama; Shugaku Takeda; Chelsea E Ray; Zhenghong Dong; Mathieu Berge; A Ari Hakimi; Sebastien Monette; Carl L Lekaye; Jason A Koutcher; Christina S Leslie; Chad J Creighton; Nils Weinhold; William Lee; Satish K Tickoo; Zhong Wang; Emily H Cheng; James J Hsieh
Journal:  Cell Rep       Date:  2017-03-21       Impact factor: 9.423

5.  Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).

Authors:  Johannes C van der Mijn; Qiuying Chen; Kristian B Laursen; Francesca Khani; Xiaofei Wang; Princesca Dorsaint; Andrea Sboner; Steven S Gross; David M Nanus; Lorraine J Gudas
Journal:  Mol Carcinog       Date:  2022-06-21       Impact factor: 5.139

Review 6.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

Review 7.  Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.

Authors:  Scott M Haake; Jamie D Weyandt; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2016-06-21       Impact factor: 5.852

8.  Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients.

Authors:  Sinisa Simonovic; Christian Hinze; Kai M Schmidt-Ott; Jonas Busch; Monika Jung; Klaus Jung; Anja Rabien
Journal:  BMC Urol       Date:  2020-02-04       Impact factor: 2.264

9.  Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma.

Authors:  Johannes C van der Mijn; Leiping Fu; Francesca Khani; Tuo Zhang; Ana M Molina; Christopher E Barbieri; Qiuying Chen; Steven S Gross; Lorraine J Gudas; David M Nanus
Journal:  Transl Oncol       Date:  2019-12-19       Impact factor: 4.243

10.  HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.

Authors:  Rouven Hoefflin; Sabine Harlander; Silvia Schäfer; Patrick Metzger; Fengshen Kuo; Désirée Schönenberger; Mojca Adlesic; Asin Peighambari; Philipp Seidel; Chia-Yi Chen; Miguel Consenza-Contreras; Andreas Jud; Bernd Lahrmann; Niels Grabe; Danijela Heide; Franziska M Uhl; Timothy A Chan; Justus Duyster; Robert Zeiser; Christoph Schell; Mathias Heikenwalder; Oliver Schilling; A Ari Hakimi; Melanie Boerries; Ian J Frew
Journal:  Nat Commun       Date:  2020-08-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.